COM:CRISPRTX
CRISPR Therapeutics AG
- Stock
Last Close
46.29
22/11 21:00
Market Cap
4.72B
Beta: -
Volume Today
1.50M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -6.80M - | -25.83M 279.82% | -23.20M 10.17% | -68.36M 194.62% | -164.98M 141.35% | 66.86M 140.52% | -348.87M 621.80% | 377.66M 208.25% | -650.17M 272.16% | -153.61M 76.37% | |
depreciation and amortization | 38K - | 127K 234.21% | 925K 628.35% | 3.02M 226.92% | 3.52M 16.37% | 4.72M 34.27% | 9.18M 94.37% | 17.95M 95.48% | 24.17M 34.64% | 19.84M 17.93% | |
deferred income tax | -20K - | -53.71M 268,440% | 4.28M - | ||||||||
stock based compensation | 695K - | 3.68M 430.07% | 10.84M 194.35% | 18.87M 74.04% | 34.98M 85.37% | 44.06M 25.93% | 66.02M 49.85% | 102.39M 55.09% | 97.95M 4.34% | 81.03M 17.27% | |
change in working capital | 1.53M - | 81.37M 5,204.30% | 1.78M 97.81% | -25.39M 1,525.66% | 10.55M 141.55% | -48.43M 559.05% | 33.44M 169.05% | 26.86M 19.68% | 19.84M 26.11% | -193.59M 1,075.49% | |
accounts receivables | -339K - | -2.82M 731.27% | 531K 118.84% | 2.54M 377.97% | -11K 100.43% | -45K 309.09% | -161K 257.78% | 305K 289.44% | -200M 65,673.77% | ||
inventory | -1.09M - | -551.30M 50,570.77% | 332.30M 160.28% | -5.03M 101.51% | -25.75M 412.38% | -37.51M 45.70% | 23.33M - | ||||
accounts payables | 3.86M - | 546.62M 14,061.14% | -323.28M 159.14% | 5.03M 101.55% | 25.75M 412.38% | 37.51M 45.70% | 5.16M 86.23% | -20.25M 492.08% | |||
other working capital | 1.53M - | 81.71M 5,226.40% | 1.83M 97.76% | -21.24M 1,262.78% | -1.00M 95.27% | -48.42M 4,717.81% | 33.48M 169.16% | 27.02M 19.31% | 14.38M 46.79% | 3.33M 76.82% | |
other non cash items | -260K - | 97K 137.31% | 8.05M 8,198.97% | 1.75M 78.21% | 15.41M 778.73% | -10.53M 168.34% | 1.86M 117.63% | 14.11M 659.77% | 12.47M 11.62% | -14.04M 212.63% | |
net cash provided by operating activities | -4.79M - | 59.43M 1,339.89% | -55.31M 193.07% | -70.10M 26.73% | -96.24M 37.29% | 56.68M 158.89% | -238.37M 520.57% | 538.97M 326.11% | -495.74M 191.98% | -260.38M 47.48% | |
investments in property plant and equipment | -1.15M - | -3.02M 161.35% | -7.81M 159.08% | -2.77M 64.51% | -6.68M 141.04% | -18.36M 174.66% | -81.70M 345.06% | -37.19M 54.49% | -11.97M 67.81% | ||
acquisitions net | -100K - | 8.01M - | 522.81M 6,427.81% | 953.73M 82.42% | 221.47M 76.78% | 2.50M 98.87% | |||||
purchases of investments | -500K - | -594.00M - | -1.51B 154.10% | -1.42B 6.06% | -1.07B 24.82% | ||||||
sales maturities of investments | 71.19M - | 555.60M 680.49% | 1.20B 115.32% | 1.45B 21.42% | |||||||
other investing activites | 35M - | -522.81M - | -953.73M 82.42% | -221.47M 76.78% | -2.50M 98.87% | ||||||
net cash used for investing activites | -1.15M - | 31.88M 2,862.91% | -8.31M 126.08% | -2.77M 66.65% | 1.32M 147.78% | -541.17M 40,943.02% | -1.04B 91.33% | -258.65M 75.02% | 374.65M 244.84% | ||
debt repayment | |||||||||||
common stock issued | 22K - | 89.06M - | 307.05M - | 415.02M 35.16% | 982.29M 136.69% | 213.27M 78.29% | 970K 99.55% | 32.72M 3,273.30% | |||
common stock repurchased | -57K - | ||||||||||
dividends paid | |||||||||||
other financing activites | 5.10M - | 96.73M 1,796.35% | 94.16M 2.66% | 2.61M 97.23% | 8.94M 242.71% | 15.96M 78.61% | 33.86M 112.12% | 37.68M 11.27% | 37.62M 0.15% | 29.94M 20.41% | |
net cash used provided by financing activities | 5.12M - | 96.73M 1,788.21% | 183.22M 89.41% | 2.61M 98.58% | 315.93M 12,014.03% | 430.98M 36.42% | 1.02B 135.78% | 250.94M 75.30% | 38.59M 84.62% | 62.66M 62.38% | |
effect of forex changes on cash | 254K - | 9K 96.46% | -235K 2,711.11% | 41K 117.45% | -22K 153.66% | 15K 168.18% | 40K 166.67% | -11K 127.50% | -80K 627.27% | 73K 191.25% | |
net change in cash | 584K - | 155.02M 26,443.84% | 159.56M 2.93% | -75.76M 147.48% | 216.90M 386.29% | 489M 125.45% | 236.66M 51.60% | -245.52M 203.75% | -715.88M 191.57% | 177.01M 124.73% | |
cash at beginning of period | 361K - | 945K 161.77% | 155.96M 16,403.81% | 315.52M 102.31% | 242.91M 23.01% | 459.81M 89.29% | 948.81M 106.35% | 1.19B 24.94% | 939.94M 20.71% | 224.06M 76.16% | |
cash at end of period | 945K - | 155.96M 16,403.81% | 315.52M 102.31% | 239.76M 24.01% | 459.81M 91.78% | 948.81M 106.35% | 1.19B 24.94% | 939.94M 20.71% | 224.06M 76.16% | 401.07M 79.00% | |
operating cash flow | -4.79M - | 59.43M 1,339.89% | -55.31M 193.07% | -70.10M 26.73% | -96.24M 37.29% | 56.68M 158.89% | -238.37M 520.57% | 538.97M 326.11% | -495.74M 191.98% | -260.38M 47.48% | |
capital expenditure | -1.15M - | -3.02M 161.35% | -7.81M 159.08% | -2.77M 64.51% | -6.68M 141.04% | -18.36M 174.66% | -81.70M 345.06% | -37.19M 54.49% | -11.97M 67.81% | ||
free cash flow | -4.79M - | 58.27M 1,315.81% | -58.33M 200.09% | -77.91M 33.58% | -99.01M 27.08% | 49.99M 150.49% | -256.72M 613.52% | 457.27M 278.12% | -532.93M 216.55% | -272.35M 48.90% |
All numbers in (except ratios and percentages)